VBI vaccines starts clinical trials for multivalent coronavirus vaccine candidate 29-Sep-2022 By Rachel Arthur VBI Vaccines has started enrollment in a Phase 1 clinical study of VBI-2901, a multivalent enveloped virus-like particle (eVLP) coronavirus vaccine candidate targeting SARS, COVID-19 and MERS.